Causal Effects Of A Hepatic Senescence Gene Set On MASLD Fibrosis: A Mendelian Randomization Study And Quercetin Molecular Docking Analysis

Aging Pathway
Therapeutic
Analytical
A specific gene, GBP2, was found to be causally linked to liver fibrosis and cholangiocarcinoma, and the natural compound quercetin shows potential to reduce liver aging by influencing this gene.
Author

Gemini

Published

March 29, 2026

Scientists have been exploring the complex ways our genes influence liver health, particularly in conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), a common liver condition. A recent study used advanced genetic analysis to investigate the role of a group of genes linked to cellular aging in the liver. They discovered a significant connection between a specific gene, called GBP2, and the development of liver fibrosis, which is the scarring of the liver. Interestingly, this same gene appeared to have a protective effect against a type of liver cancer called cholangiocarcinoma.

The research also looked into potential ways to intervene. Using computer modeling, they explored how a natural compound called quercetin, found in many fruits and vegetables, might interact with these aging-related genes. The findings suggest that quercetin could indirectly influence the GBP2 gene, potentially slowing down the aging process in the liver and offering a new avenue for developing treatments to combat liver fibrosis.


Source: link to paper